Artificial intelligence programs now scan M.R.I.s for cancer, AirPods double as hearing aids, and devices revive speech, significantly transforming patient care.
Dr. Michelle Tarver's appointment comes at a time of increased scrutiny on device approvals and industry ties, recognizing the necessity for stringent regulations on medical technologies.
The budget of the device division is approximately $790 million with a dedicated staff of 2,500, underscoring the need for rigorous oversight especially as innovations develop rapidly.
Among Dr. Tarver's challenges are overseeing the regulation of complex technologies like brain-computer interfaces, which restore functions lost due to neurological conditions.
Collection
[
|
...
]